#BIOLABS #BIOCoin

Binance Labs, the venture capital arm of Binance, has made a strategic investment in BIO Protocol, an innovative project that aims to revolutionize the funding and commercialization of early-stage scientific research through blockchain technology.

About BIO Protocol:

Decentralized Science (DeSci): BIO Protocol serves as a platform that enables a global community—comprised of scientists, patients, and investors—to collectively fund, develop, and own new medicines and therapies through a network of Biotech Decentralized Autonomous Organizations (BioDAOs).

Research Focus: The protocol targets funding gaps in traditional scientific research, specifically in areas such as rare diseases, longevity research, and other emerging health challenges.

BioDAOs Network: BIO Protocol currently has seven BioDAOs focused on areas including cryopreservation, women’s health, and the use of psychedelics for mental health treatments.

Development Plans:

Upcoming Projects: BIO Protocol plans to expand its network with projects focused on developing treatments for Long COVID, rare diseases, and developing quantum microscopes to observe quantum biology phenomena.

Ecosystem Expansion: The investment from Binance Labs will be used to seed fund new BioDAOs and strengthen the network of service providers offering community and tokenomics support.

Official Statement:

Andy Chang, Chief Investment Officer at Binance Labs: "BIO Protocol represents a significant step forward in DeSci by merging biotech and DeFi. We are committed to driving real long-term impact by supporting projects that build meaningful technology."

Paul Kohlhaas, Founder of BIO Protocol: "The support from Binance Labs will help us unlock scientific breakthroughs from Boston to Singapore to Bangalore, catalyzing patient-led research at a scale that was previously impossible."